Izokibep Demonstrates Clinically Relevant Efficacy Benefits on Enthesitis, Dactylitis and Nail Outcomes in Active PsA Patients: A 16-week Randomized, Placebo-controlled Trial

Authors
Category Primary study
ConferenceArthritis and Rheumatology
Year 2022
This article has no abstract
Epistemonikos ID: 95f4c3f477bdc238d95cfea359c2e8a3fd384404
First added on: Apr 30, 2026